{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:17:10Z","timestamp":1754144230555,"version":"3.41.2"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.riam.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T10:46:45Z","timestamp":1743936405000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-life experience on the use of isavuconazole in solid organ transplantation"],"prefix":"10.1016","volume":"42","author":[{"given":"Jose Tiago","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2025.02.004_bib0225","doi-asserted-by":"crossref","first-page":"e13313","DOI":"10.1111\/tid.13313","article-title":"Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient","volume":"22","author":"Assaf","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/17512433.2024.2317293","article-title":"Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?","volume":"17","author":"Boyer","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.riam.2025.02.004_bib0235","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0240","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.3390\/pharmaceutics13111961","article-title":"The overview on the pharmacokinetic and pharmacodynamic interactions of triazoles","volume":"13","author":"Czyrski","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.riam.2025.02.004_bib0245","doi-asserted-by":"crossref","first-page":"e13197","DOI":"10.1111\/tid.13197","article-title":"Successful treatment with isavuconazole of subcutaneous phaeohyphomycosis in a kidney transplant recipient","volume":"21","author":"Dalla Gasperina","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0250","doi-asserted-by":"crossref","first-page":"444","DOI":"10.14712\/23362936.2023.34","article-title":"Demonstration of the rationale for therapeutic drug monitoring of isavuconazole: a case report with a lung transplant recipient","volume":"124","author":"Dvo\u0159\u00e1\u010dkov\u00e1","year":"2023","journal-title":"Prague Med Rep"},{"key":"10.1016\/j.riam.2025.02.004_bib0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.12283","article-title":"Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study","volume":"58","author":"Falci","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.riam.2025.02.004_bib0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/TP.0000000000004312","article-title":"Isavuconazole for the treatment of invasive mold disease in solid organ transplant recipients: a multicenter study on efficacy and safety in real-life clinical practice","volume":"107","author":"Fernandez-Ruiz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.riam.2025.02.004_bib0265","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1097\/TP.0000000000005082","article-title":"Isavuconazole versus voriconazole as the first-line therapy for solid organ transplant recipients with invasive aspergillosis: comparative analysis of 2 multicenter cohort studies","volume":"108","author":"Fern\u00e1ndez-Ruiz","year":"2024","journal-title":"Transplantation"},{"issue":"Suppl. 2","key":"10.1016\/j.riam.2025.02.004_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0213-005X(12)70082-4","article-title":"Fungal infection in solid organ recipients","volume":"30","author":"Fortun","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.riam.2025.02.004_bib0275","first-page":"e46308","article-title":"Unusual Aspergillus pleural effusion in a patient with immunodeficiency","volume":"15","author":"Fortuzi","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.riam.2025.02.004_bib0280","first-page":"9839780","article-title":"Gastric mucormycosis in a renal transplant patient treated with isavuconazole monotherapy","volume":"2019","author":"Gani","year":"2019","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.riam.2025.02.004_bib0285","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eimc.2018.03.018","article-title":"Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 update by the GEMICOMED-SEIMC\/REIPI","volume":"37","author":"Garcia-Vidal","year":"2019","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"key":"10.1016\/j.riam.2025.02.004_bib0290","article-title":"Aspergillus granulosus femoral osteomyelitis in a cardiac transplant patient: first reported case and literature review","volume":"11","author":"Giacinta","year":"2024","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0295","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/myc.13298","article-title":"Invasive aspergillosis in solid organ transplantation: diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)","volume":"64","author":"Gioia","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.riam.2025.02.004_bib0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/cpdd.284","article-title":"Pharmacokinetic assessment of drug\u2013drug interactions of isavuconazole with the immunosuppressants cyclosporine, mycophenolic acid, prednisolone, sirolimus, and tacrolimus in healthy adults","volume":"6","author":"Groll","year":"2017","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.riam.2025.02.004_bib0305","doi-asserted-by":"crossref","first-page":"e12751","DOI":"10.1111\/tid.12751","article-title":"Drug\u2013drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4","volume":"19","author":"Groll","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0310","first-page":"7323755","article-title":"Azole-induced myositis after combined lung-liver transplantation","volume":"2022","author":"Happaerts","year":"2022","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.riam.2025.02.004_bib0315","doi-asserted-by":"crossref","first-page":"e01240","DOI":"10.1016\/j.idcr.2021.e01240","article-title":"Cerebral and pulmonary phaeohyphomycosis due Cladophialophora bantiana in an immunocompromised patient","volume":"25","author":"Hernandez","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.riam.2025.02.004_bib0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.riam.2025.02.004_bib0325","doi-asserted-by":"crossref","first-page":"e12878","DOI":"10.1111\/tid.12878","article-title":"Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation","volume":"20","author":"Kabulski","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccm.2017.04.011","article-title":"Fungal infections after lung transplantation","volume":"38","author":"Kennedy","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.riam.2025.02.004_bib0335","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jcpt.12308","article-title":"Drug\u2013drug interaction between isavuconazole and tacrolimus: a case report indicating the need for tacrolimus drug-level monitoring","volume":"40","author":"Kim","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.riam.2025.02.004_bib0340","first-page":"16156","article-title":"Colon mucormycosis with renal spread resistant to lipid complex amphotericin and isavuconazole treatment in a heart transplant recipient","volume":"132","author":"Lango-Maziarz","year":"2022","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.riam.2025.02.004_bib0345","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.idc.2018.04.006","article-title":"Mold infections in solid organ transplant recipients","volume":"32","author":"Lemonovich","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.riam.2025.02.004_bib0350","doi-asserted-by":"crossref","first-page":"e0017722","DOI":"10.1128\/aac.00177-22","article-title":"New perspectives on antimicrobial agents: isavuconazole","volume":"66","author":"Lewis","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2025.02.004_bib0355","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/ajt.13837","article-title":"Clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study","volume":"16","author":"Lopez-Medrano","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.riam.2025.02.004_bib0360","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.riam.2025.02.004_bib0365","doi-asserted-by":"crossref","first-page":"101235","DOI":"10.1016\/j.mycmed.2021.101235","article-title":"Intricate isavuconazole therapy of a subcutaneous nodule caused by Alternaria infectoria in a heart transplant recipient","volume":"32","author":"Maisons","year":"2022","journal-title":"J Mycol Med"},{"key":"10.1016\/j.riam.2025.02.004_bib0370","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case\u2013control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0375","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/phar.2850","article-title":"Utility of triazole antifungal therapeutic drug monitoring: insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium","volume":"43","author":"McCreary","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.riam.2025.02.004_bib0380","doi-asserted-by":"crossref","first-page":"e14049","DOI":"10.1111\/tid.14049","article-title":"Invasive aspergillosis in liver transplant recipients","volume":"25","author":"Melenotte","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0385","doi-asserted-by":"crossref","first-page":"e0178421","DOI":"10.1128\/spectrum.01784-21","article-title":"Safety and effectiveness of isavuconazole treatment for fungal infections in solid organ transplant recipients (ISASOT Study)","volume":"10","author":"Monforte","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.riam.2025.02.004_bib0390","doi-asserted-by":"crossref","first-page":"e12898","DOI":"10.1111\/tid.12898","article-title":"Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study","volume":"20","author":"Neofytos","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0395","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12879-021-05958-3","article-title":"Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response","volume":"21","author":"Neofytos","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0400","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.16248","article-title":"Risk factors for the development of invasive aspergillosis after kidney transplantation: systematic review and meta-analysis","volume":"21","author":"Perez-Jacoiste Asin","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.riam.2025.02.004_bib0405","doi-asserted-by":"crossref","first-page":"e00305","DOI":"10.1128\/AAC.00305-17","article-title":"Combination therapy with isavuconazole and micafungin for treatment of experimental invasive pulmonary aspergillosis","volume":"61","author":"Petraitis","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2025.02.004_bib0410","doi-asserted-by":"crossref","first-page":"e00970","DOI":"10.1128\/AAC.00970-17","article-title":"Effects of isavuconazole on the plasma concentrations of tacrolimus among solid-organ transplant patients","volume":"61","author":"Rivosecchi","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.riam.2025.02.004_bib0415","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cid\/ciaa652","article-title":"Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients","volume":"73","author":"Samanta","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2025.02.004_bib0420","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.riam.2018.05.002","article-title":"Invasive aspergillosis in solid organ transplantation","volume":"35","author":"Silva","year":"2018","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.riam.2025.02.004_bib0425","doi-asserted-by":"crossref","first-page":"e13501","DOI":"10.1111\/tid.13501","article-title":"Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient","volume":"23","author":"Trujillo","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.riam.2025.02.004_bib0430","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2025.02.004_bib0435","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s15010-019-01360-z","article-title":"Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response","volume":"47","author":"Welte","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.riam.2025.02.004_bib0440","doi-asserted-by":"crossref","first-page":"e01643","DOI":"10.1128\/AAC.01643-18","article-title":"Pharmacokinetics of intravenous isavuconazole in solid-organ transplant recipients","volume":"62","author":"Wu","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140625000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140625000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T10:25:56Z","timestamp":1752575156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140625000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1130140625000191"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2025.02.004","relation":{},"ISSN":["1130-1406"],"issn-type":[{"type":"print","value":"1130-1406"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life experience on the use of isavuconazole in solid organ transplantation","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}